A 57-year-old with recurrent unprovoked VTE completes 6 months of apixaban 5 mg BID and has low bleeding risk. What long-term approach is recommended?...

Question

A 57-year-old with recurrent unprovoked VTE completes 6 months of apixaban 5 mg BID and has low bleeding risk. What long-term approach is recommended?

Accepted Answer

Continue apixaban 2.5 mg BID for extended therapy

Answer

Stop anticoagulation now

Answer

Switch to warfarin indefinitely

Answer

Aspirin only

Answer

Intermittent prophylaxis during travel only

us-abim MCQ (SBA): VTE (Extended Therapy)

A 57-year-old with recurrent unprovoked VTE completes 6 months of apixaban 5 mg BID and has low bleeding risk. What long-term approach is recommended?